IFNG and neoplasm: Twenty-one days after the tumor-cell injection, the self-Ag-specific IFN-γ production in the tumor-drLN cells after the combined treatment of self-Ag and FimH was significantly higher than it had been with the other treatments (Fig. 5e, f).